These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. "Switchboard" malfunction in motor neuron diseases: Selective pathology of thalamic nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis. Chipika RH; Finegan E; Li Hi Shing S; McKenna MC; Christidi F; Chang KM; Doherty MA; Hengeveld JC; Vajda A; Pender N; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O; Bede P Neuroimage Clin; 2020; 27():102300. PubMed ID: 32554322 [TBL] [Abstract][Full Text] [Related]
7. Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): A cognitive tool for motor disorders. Niven E; Newton J; Foley J; Colville S; Swingler R; Chandran S; Bak TH; Abrahams S Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):172-9. PubMed ID: 25967542 [TBL] [Abstract][Full Text] [Related]
8. Validation of The Edinburgh cognitive and behavioural ALS screen (ECAS) in behavioural variant frontotemporal dementia and Alzheimer's disease. De Icaza Valenzuela MM; Bak TH; Thompson HE; Colville S; Pal S; Abrahams S Int J Geriatr Psychiatry; 2021 Oct; 36(10):1576-1587. PubMed ID: 33983668 [TBL] [Abstract][Full Text] [Related]
9. The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese Amyotrophic Lateral Sclerosis Population. Ye S; Ji Y; Li C; He J; Liu X; Fan D PLoS One; 2016; 11(5):e0155496. PubMed ID: 27195772 [TBL] [Abstract][Full Text] [Related]
11. Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis. Saxon JA; Thompson JC; Harris JM; Richardson AM; Langheinrich T; Rollinson S; Pickering-Brown S; Chaouch A; Ealing J; Hamdalla H; Young CA; Blackburn D; Majeed T; Gall C; Jones M; Snowden JS J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1304-1311. PubMed ID: 33055142 [TBL] [Abstract][Full Text] [Related]
12. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: Frequency of abnormality and effect on survival. Xu Z; Alruwaili ARS; Henderson RD; McCombe PA J Neurol Sci; 2017 May; 376():16-23. PubMed ID: 28431606 [TBL] [Abstract][Full Text] [Related]
13. Genotypes and phenotypes of motor neuron disease: an update of the genetic landscape in Scotland. Leighton DJ; Ansari M; Newton J; Cleary E; Stephenson L; Beswick E; Carod Artal J; Davenport R; Duncan C; Gorrie GH; Morrison I; Swingler R; Deary IJ; Porteous M; Chandran S; Pal S; J Neurol; 2024 Aug; 271(8):5256-5266. PubMed ID: 38852112 [TBL] [Abstract][Full Text] [Related]
14. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline. Troakes C; Maekawa S; Wijesekera L; Rogelj B; Siklós L; Bell C; Smith B; Newhouse S; Vance C; Johnson L; Hortobágyi T; Shatunov A; Al-Chalabi A; Leigh N; Shaw CE; King A; Al-Sarraj S Neuropathology; 2012 Oct; 32(5):505-14. PubMed ID: 22181065 [TBL] [Abstract][Full Text] [Related]
15. Sensitivity and specificity of the ECAS in identifying executive function and social cognition deficits in MND. Tjokrowijoto P; Phillips M; Ceslis A; Henderson RD; McCombe PA; Robinson GA Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; 24(5-6):466-474. PubMed ID: 36967700 [No Abstract] [Full Text] [Related]
16. Longitudinal assessment of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): lack of practice effect in ALS patients? Burkhardt C; Neuwirth C; Weber M Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):202-209. PubMed ID: 28165766 [TBL] [Abstract][Full Text] [Related]
17. Arabic adaptation of the Edinburgh cognitive and behavioural Amyotrophic lateral sclerosis screen (ECAS-AR). Kacem I; Abida Y; Ferchichi W; Mrabet S; Sghaier I; Gharbi A; Souissi A; Nasri A; Gargouri A; Ben Djebara M; Gouider R Rev Neurol (Paris); 2022 Oct; 178(8):817-825. PubMed ID: 35570063 [TBL] [Abstract][Full Text] [Related]
18. Structural and functional brain signatures of C9orf72 in motor neuron disease. Agosta F; Ferraro PM; Riva N; Spinelli EG; Domi T; Carrera P; Copetti M; Falzone Y; Ferrari M; Lunetta C; Comi G; Falini A; Quattrini A; Filippi M Neurobiol Aging; 2017 Sep; 57():206-219. PubMed ID: 28666709 [TBL] [Abstract][Full Text] [Related]
19. Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder. Vázquez-Costa JF; Arlandis S; Hervas D; Martínez-Cuenca E; Cardona F; Pérez-Tur J; Broseta E; Sevilla T J Neurol Sci; 2017 Jul; 378():130-136. PubMed ID: 28566149 [TBL] [Abstract][Full Text] [Related]